nach oben

Erschienen in:

01.06.2011

Self-rated health as a tool for estimating health-adjusted life expectancy among patients newly diagnosed with localized prostate cancer: a preliminary study

verfasst von: Ravinder Mohan, Hind A. Beydoun, May A. Beydoun, Myra Barnes-Eley, John Davis, Raymond Lance, Paul Schellhammer

Erschienen in: Quality of Life Research | Ausgabe 5/2011

Einloggen

Aktivieren Sie unsere intelligente Suche, um passende Fachinhalte oder Patente zu finden.

search-config

KI-gestützte Suche

Aus

Abstract

Purpose

Localized prostate cancer (LPC) patients are faced with numerous treatment options, including observation or watchful waiting. The choice of treatment largely depends on their baseline health-adjusted life expectancy (HALE). By consensus, physicians recommend treatment if the patient’s HALE is ten or more years. However, the estimation of HALE is difficult. Although subjective by nature, self-rated health (SRH) is a robust predictor of mortality. We studied the usefulness of SRH in estimating HALE in patients who are considering treatment for LPC.

Methods

A total of 144 LPC patients from a large urology private practice in Norfolk, Virginia, were surveyed before they had chosen a treatment option.

Results

HALE determined by SRH correlated well with objective health measures and was higher than age-based life expectancy by an average of 2 years. The observed difference in life expectancy due to SRH adjustment was higher among patients with a better socioeconomic and health profile.

Conclusions

SRH is an easy-to-use indicator of HALE in LPC patients. A table for HALE estimation by age and SRH is provided for men aged 70–80 years. Additional research with larger samples and prospective study designs are needed before the SRH method can be used in primary care and urology settings.

Vorheriger Artikel Predictors of quality of life in carers for people with a progressive neurological illness: a longitudinal study

Nächster Artikel The prevalence of urinary incontinence and its burden on the quality of life among older adults with medicare supplement insurance

Sie haben noch keine Lizenz? Dann Informieren Sie sich jetzt über unsere Produkte:

Springer Professional "Wirtschaft+Technik"

Online-Abonnement

Mit Springer Professional "Wirtschaft+Technik" erhalten Sie Zugriff auf:

über 102.000 Bücher
über 537 Zeitschriften

aus folgenden Fachgebieten:

Automobil + Motoren
Bauwesen + Immobilien
Business IT + Informatik
Elektrotechnik + Elektronik
Energie + Nachhaltigkeit
Finance + Banking
Management + Führung
Marketing + Vertrieb
Maschinenbau + Werkstoffe
Versicherung + Risiko

Jetzt Wissensvorsprung sichern!

Jetzt informieren

Springer Professional "Wirtschaft"

Online-Abonnement

Mit Springer Professional "Wirtschaft" erhalten Sie Zugriff auf:

über 67.000 Bücher
über 340 Zeitschriften

aus folgenden Fachgebieten:

Bauwesen + Immobilien
Business IT + Informatik
Finance + Banking
Management + Führung
Marketing + Vertrieb
Versicherung + Risiko

Jetzt Wissensvorsprung sichern!

Jetzt informieren

Harlan, S. R., Cooperberg, M. R., Elkin, E. P., Lubeck, D. P., Meng, M. V., Mehta, S. S., et al. (2003). Time trends and characteristics of men choosing watchful waiting for initial treatment of localized prostate cancer: Results from CaPSURE. The Journal of urology, 170(5), 1804–1807.PubMedCrossRef

Parker, C., Muston, D., Melia, J., Moss, S., & Dearnaley, D. (2006). A model of the natural history of screen-detected prostate cancer, and the effect of radical treatment on overall survival. British Journal of Cancer, 94(10), 1361–1368.PubMedCrossRef

Wilson, J. R., Clarke, M. G., Ewings, P., Graham, J. D., & MacDonagh, R. (2005). The assessment of patient life-expectancy: How accurate are urologists and oncologists? BJU International, 95(6), 794–798.PubMedCrossRef

Taichman, R. S., Loberg, R. D., Mehra, R., & Pienta, K. J. (2007). The evolving biology and treatment of prostate cancer. The Journal of Clinical Investigation, 117(9), 2351–2361.PubMedCrossRef

Jemal, A., Siegel, R., Ward, E., Murray, T., Xu, J., & Thun, M. J. (2007). Cancer statistics, 2007. CA: A Cancer Journal for Clinicians, 57(1), 43–66.CrossRef

Klotz, L. (2005). Active surveillance for prostate cancer: For whom? Journal of Clinical Oncology, 23(32), 8165–8169.PubMedCrossRef

Post, P. N., Hansen, B. E., Kil, P. J., Janssen-Heijnen, M. L., & Coebergh, J. W. (2001). The independent prognostic value of comorbidity among men aged <75 years with localized prostate cancer: A population-based study. BJU International, 87(9), 821–826.PubMedCrossRef

van den Bergh, R. C., Roemeling, S., Roobol, M. J., Aus, G., Hugosson, J., Rannikko, A. S., Tammela, T. L., Bangma, C. H., & Schroder, F. H. (2008). Outcomes of men with screen-detected prostate cancer eligible for active surveillance who were managed expectantly. European Urology.

Ruchlin, H. S., & Pellissier, J. M. (2001). An economic overview of prostate carcinoma. Cancer, 92(11), 2796–2810.PubMedCrossRef

10.

Miller, D. C., Gruber, S. B., Hollenbeck, B. K., Montie, J. E., & Wei, J. T. (2006). Incidence of initial local therapy among men with lower-risk prostate cancer in the United States. Journal of the National Cancer Institute, 98(16), 1134–1141.PubMedCrossRef

11.

Dahm, P., Kunz, R., & Schunemann, H. (2007). Evidence-based clinical practice guidelines for prostate cancer: The need for a unified approach. Current Opinion in Urology, 17(3), 200–207.PubMedCrossRef

12.

McCloskey, S. A., & Kuettel, M. R. (2007). Counterpoint: Prostate cancer life expectancy can not be accurately predicted from currently available tools. Journal of the National Comprehensive Cancer Network, 5(7), 709–713.PubMed

13.

Kistler, C. E., Lewis, C. L., Amick, H. R., Bynum, D. L., Walter, L. C., & Watson, L. C. (2006). Older adults’ beliefs about physician-estimated life expectancy: A cross-sectional survey. BMC Family Practice, 7, 9.PubMedCrossRef

14.

Walz, J., Gallina, A., Hutterer, G., Perrotte, P., Shariat, S. F., Graefen, M., et al. (2007). Accuracy of life tables in predicting overall survival in candidates for radiotherapy for prostate cancer. International Journal of Radiation Oncology, Biology, Physics, 69(1), 88–94.PubMedCrossRef

15.

Walter, L. C., & Covinsky, K. E. (2001). Cancer screening in elderly patients: A framework for individualized decision making. JAMA, 285(21), 2750–2756.PubMedCrossRef

16.

Cohen, H., & Britten, N. (2003). Who decides about prostate cancer treatment? A qualitative study. Family Practice, 20(6), 724–729.PubMedCrossRef

17.

Welch, H. G., Albertsen, P. C., Nease, R. F., Bubolz, T. A., & Wasson, J. H. (1996). Estimating treatment benefits for the elderly: The effect of competing risks. Annals of Internal Medicine, 124(6), 577–584.PubMed

18.

Mohan, R., Beydoun, H., Barnes-Ely, M. L., Lee, L., Davis, J. W., Lance, R., et al. (2009). Patients’ survival expectations before localized prostate cancer treatment by treatment status. Journal of the American Board of Family Medicine, 22(3), 247–256.PubMedCrossRef

19.

NCHS. (2007). In National Vital Statistics Report 54 (14). 28 March 2007.

20.

Fowler, F. J., Jr., McNaughton Collins, M., Albertsen, P. C., Zietman, A., Elliott, D. B., & Barry, M. J. (2000). Comparison of recommendations by urologists and radiation oncologists for treatment of clinically localized prostate cancer. JAMA, 283(24), 3217–3222.PubMedCrossRef

21.

Potosky, A. L., Harlan, L. C., Stanford, J. L., Gilliland, F. D., Hamilton, A. S., Albertsen, P. C., et al. (1999). Prostate cancer practice patterns and quality of life: The prostate cancer outcomes study. Journal of the National Cancer Institute, 91(20), 1719–1724.PubMedCrossRef

22.

Chaudhry, S., Jin, L., & Meltzer, D. (2005). Use of a self-report-generated Charlson comorbidity index for predicting mortality. Medical Care, 43(6), 607–615.PubMedCrossRef

23.

Hlatky, M. A., Boineau, R. E., Higginbotham, M. B., Lee, K. L., Mark, D. B., Califf, R. M., et al. (1989). A brief self-administered questionnaire to determine functional capacity (The duke activity status index). The American journal of cardiology, 64(10), 651–654.PubMedCrossRef

24.

Hamilton, D. M., & Haennel, R. G. (2000). Validity and reliability of the 6 min walk test in a cardiac rehabilitation population. Journal of Cardiopulmonary Rehabilitation, 20(3), 156–164.PubMedCrossRef

25.

Lee, I. M., Hsieh, C. C., & Paffenbarger, R. S., Jr. (1995). Exercise intensity and longevity in men. The Harvard alumni health study. JAMA, 273(15), 1179–1184.PubMedCrossRef

26.

Zigmond, A. S., & Snaith, R. P. (1983). The hospital anxiety and depression scale. Acta Psychiatrica Scandinavica, 67(6), 361–370.PubMedCrossRef

27.

Baigi, A., Hildingh, C., Virdhall, H., & Fridlund, B. (2008). Sense of coherence as well as social support and network as perceived by patients with a suspected or manifest myocardial infarction: A short-term follow-up study. Clinical Rehabilitation, 22(7), 646–652.PubMedCrossRef

28.

Zahran, H. S., Kobau, R., Moriarty, D. G., Zack, M. M., Holt, J., & Donehoo, R. (2005). Health-related quality of life surveillance—United States, 1993–2002. MMWR Surveillance Summaries, 54(4), 1–35.

29.

Mossey, J. M., & Shapiro, E. (1982). Self-rated health: a predictor of mortality among the elderly. American Journal of Public Health, 72(8), 800–808.PubMedCrossRef

30.

DeSalvo, K. B., Bloser, N., Reynolds, K., He, J., & Muntner, P. (2006). Mortality prediction with a single general self-rated health question. A meta-analysis. Journal of General Internal Medicine, 21(3), 267–275.PubMedCrossRef

31.

Carson, C. (2007). Private practice or academia- making the choice. Urology Times. Feb 2007.

Titel: Self-rated health as a tool for estimating health-adjusted life expectancy among patients newly diagnosed with localized prostate cancer: a preliminary study
verfasst von: Ravinder Mohan
Hind A. Beydoun
May A. Beydoun
Myra Barnes-Eley
John Davis
Raymond Lance
Paul Schellhammer
Publikationsdatum: 01.06.2011
Verlag: Springer Netherlands
Erschienen in: Quality of Life Research / Ausgabe 5/2011
Print ISSN: 0962-9343
Elektronische ISSN: 1573-2649
DOI: https://doi.org/10.1007/s11136-010-9805-3

Springer Professional

Abstract

Purpose

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu Ihrer Lizenz zu erhalten.

Sie haben noch keine Lizenz? Dann Informieren Sie sich jetzt über unsere Produkte:

Springer Professional "Wirtschaft+Technik"

Springer Professional "Wirtschaft"

Weitere Artikel der Ausgabe 5/2011

Prevalence of complementary/alternative medicines (CAMs) in a cancer population in northern Italy receiving antineoplastic treatments and relationship with quality of life and psychometric features

Psychometric properties of the Spanish form of the schedule for meaning in life evaluation (SMiLE)

Anhedonia is associated with poor health status and more somatic and cognitive symptoms in patients with coronary artery disease

Measurement properties of the Community Wellbeing Index in older adults

Changes in SWB following injury to different brain lobes

Patterns of reporting health-related quality of life outcomes in randomized clinical trials: implications for clinicians and quality of life researchers

Premium Partner